“Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE)” (2019) Reumatismo, 71(1), pp. 24–30. doi:10.4081/reumatismo.2019.1154.